Eleanor T. Mcfadden

机构：Frontier Agriculture (United Kingdom)

发表论文 47 篇 · 总被引 21619 次 · h-index 17

代表论文

• Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer (2021 · New England Journal of Medicine · 被引 1730)
• 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial (2017 · The Lancet · 被引 1050)
• 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial (2013 · The Lancet · 被引 502)
• Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial (2015 · Journal of Clinical Oncology · 被引 377)
• Population-Based Colonoscopy Screening for Colorectal Cancer (2016 · JAMA Internal Medicine · 被引 328)
• Rationale and design of the European Polyp Surveillance (EPoS) trials (2016 · Endoscopy · 被引 113)